You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Intermediate-Grade

Showing 1 - 25 of 6,743
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Carcinoma, Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8 Trial in Rochester (MRI-Guided

Not yet recruiting
  • Prostate Carcinoma
  • +2 more
  • MRI-Guided Transurethral Ultrasound Ablation
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 28, 2022

Atypical Ductal Hyperplasia, Ductal Carcinoma in Situ Trial in Milan (Vacuum-assisted excisional biopsy)

Recruiting
  • Atypical Ductal Hyperplasia
  • Ductal Carcinoma in Situ
  • Vacuum-assisted excisional biopsy
  • Milan, Italy
    Breast Imaging Division, Radiology Department, IEO European Inst
Jun 27, 2023

High Grade B-Cell Non-Hodgkin's Lymphoma, Intermediate Grade B-Cell Non-Hodgkin's Lymphoma, Recurrent B-Cell Non-Hodgkin

Not yet recruiting
  • High Grade B-Cell Non-Hodgkin's Lymphoma
  • +3 more
  • Anti-CD19-CAR CMV-specific T-lymphocytes
  • +9 more
  • Duarte, California
    City of Hope Medical Center
Apr 5, 2023

Neuroendocrine Tumors Trial in New Orleans (ABI-009)

Terminated
Has Results
  • Neuroendocrine Tumors
  • New Orleans, Louisiana
    Ochsner Clinic Foundation
May 17, 2021

Follicular Lymphoma Trial in Toronto (12 Gy in 6 daily fractions)

Recruiting
  • Follicular Lymphoma
  • 12 Gy in 6 daily fractions
  • Toronto, Ontario, Canada
    Sunnybrook Health Sciences Centre
Mar 10, 2022

Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder Trial in United States (UGN-102)

Active, not recruiting
  • Bladder Cancer
  • +2 more
  • Homewood, Alabama
  • +4 more
Dec 15, 2022

Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

Active, not recruiting
  • Adult Grade III Lymphomatoid Granulomatosis
  • +23 more
  • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Lymphoma Trial in Washington, Baltimore (rituximab, sargramostim, EPOCH regimen)

Withdrawn
  • Lymphoma
  • rituximab
  • +7 more
  • Washington, District of Columbia
  • +1 more
Oct 19, 2021

Lymphoma, Follicular, Lymphoma, Low-Grade, Lymphoma, Intermediate-Grade Trial in Munich (procedure, drug, other)

Active, not recruiting
  • Lymphoma, Follicular
  • +2 more
  • FCM
  • +3 more
  • Munich, Germany
    German Low Grade Study Group (Glsg)
May 6, 2021

B-Cell Non-Hodgkin Lymphoma, DLBCL, Mantle Cell Lymphoma Trial in Duarte (Anti-CD19-CAR CMV-specific T-lymphocytes, Autologous

Not yet recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Anti-CD19-CAR CMV-specific T-lymphocytes
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jun 28, 2022

Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Classic Hodgkin Lymphoma, Recurrent

Not yet recruiting
  • Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
  • +21 more
  • Biopsy
  • +8 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 7, 2023

Recurrent ALK Positive Large B-Cell Lymphoma, Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between

Not yet recruiting
  • Recurrent ALK Positive Large B-Cell Lymphoma
  • +28 more
  • Biospecimen Collection
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Aug 17, 2022

Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)

Active, not recruiting
Has Results
  • Brain and Central Nervous System Tumors
  • Induction Chemotherapy
  • +3 more
  • Palo Alto, California
  • +5 more
Nov 29, 2022

B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Burkitt Lymphoma, Grade 1 Follicular Lymphoma,

Active, not recruiting
  • B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma
  • +11 more
  • Atlanta, Georgia
  • +1 more
Apr 18, 2022

Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Tumors Trial run by the NCI (Sunitinib, Everolimus)

Terminated
Has Results
  • Neuroendocrine Tumors
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2020

NHL, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in United States (veltuzumab)

Completed
  • NHL
  • +17 more
  • veltuzumab
  • Savannah, Georgia
  • +4 more
Aug 12, 2021

Advanced Digestive System Neuroendocrine Tumor, Duodenal Neuroendocrine Tumor G1, Functional Pancreatic Neuroendocrine Tumor

Completed
Has Results
  • Advanced Digestive System Neuroendocrine Neoplasm
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 8, 2020

ALK-Positive Large B-Cell Lymphoma, Burkitt-Like Lymphoma With 11q Aberration, DLBCL Activated B-Cell Type Trial in United

Active, not recruiting
  • ALK-Positive Large B-Cell Lymphoma
  • +34 more
  • Phoenix, Arizona
  • +32 more
Jan 3, 2023

Aggressive Non-Hodgkin Lymphoma, ALK-Positive Large B-Cell Lymphoma, B-Cell Lymphoma, Unclassifiable, With Features Intermediate

Recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • +8 more
  • Polatuzumab Vedotin
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 26, 2023

Neuroendocrine Tumors Trial (64Cu-SARTATE)

Completed
  • Neuroendocrine Tumors
  • (no location specified)
Jun 18, 2020

Recurrent DLBCL, Recurrent Mantle Cell Lymphoma, Refractory DLBCL Trial in Duarte (Autologous

Active, not recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +4 more
  • Autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Mar 28, 2022

Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder Trial in Worldwide (UGN-102)

Recruiting
  • Bladder Cancer
  • +2 more
  • Tucson, Arizona
  • +76 more
Jul 13, 2022

Chronic Coronary Syndromes Undergoing Coronary ANGIOgraphy

Recruiting
  • Chronic Coronary Syndrome
  • +4 more
  • AID strategy
  • Alcalá De Henares, Madrid, Spain
  • +3 more
Nov 22, 2022

Aggressive Non-Hodgkin Lymphoma, Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma, Ann Arbor Stage II

Active, not recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • +13 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Aug 18, 2022

Brain and CNS Tumors Trial in Canada, United States (54 Gy radiotherapy, 60 Gy radiotherapy)

Active, not recruiting
Has Results
  • Brain and Central Nervous System Tumors
  • 54 Gy radiotherapy
  • 60 Gy radiotherapy
  • Phoenix, Arizona
  • +77 more
Dec 15, 2022